Status:
COMPLETED
Fenofibrate Therapy in Pathological Unconjugated Hyperbilirubinemia in Full Term Infants
Lead Sponsor:
Mansoura University
Conditions:
Neonatal Jaundice
Eligibility:
All Genders
Up to 28 years
Phase:
NA
Brief Summary
Background: Despite widespread phototherapy usage, many newborn infants remain in need of other lines of invasive therapy such as intravenous immunoglobulins and exchange transfusions. Objective: To ...
Eligibility Criteria
Inclusion
- we included appropriate for gestational age full-term infants with pathological unconjugated hyperbilirubinemia who are candidate for phototherapy according to American academy of pediatrics guidelines
Exclusion
- Full term infants with intrauterine growth restriction, congenital malformations, conjugated hyperbilirubinemia, severe jaundice initially required exchange transfusion, skin abrasions or infection, and preterm infants were excluded
Key Trial Info
Start Date :
June 1 2016
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04418180
Start Date
June 1 2016
Last Update
June 5 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.